These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1171764)

  • 21. Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinoside.
    Momparler RL; Chu MY; Fischer GA
    Biochim Biophys Acta; 1968 Jul; 161(2):481-93. PubMed ID: 4174433
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of cytarabine uptake and toxicity by dipyridamole.
    King ME; Naporn A; Young B; Howell SB
    Cancer Treat Rep; 1984 Feb; 68(2):361-6. PubMed ID: 6697325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).
    Chu MY; Fischer GA
    Biochem Pharmacol; 1968 May; 17(5):753-67. PubMed ID: 5689802
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI; Powell W
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
    Bukhman VM; Lichinitser MR; Svet-Moldavskiĭ GIa; Mkheidze DM
    Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of prolonged-release derivative of cytosine arabinoside, cytosine arabinoside-agarose conjugate.
    Hashida M; Kojima T; Muranishi S; Sezaki H
    Gan; 1978 Dec; 69(6):839-43. PubMed ID: 750275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS; MUSSER EA; BOSTWICK L; MENGEL GD
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.
    Fukushima M; Ikenaka K; Shirasaka T; Fujii S
    Gan; 1979 Feb; 70(1):47-53. PubMed ID: 556350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The combined effect of chlorprothixene and 4-hydroxy-5-fluoropyrimidene on the protein synthesis of various tumour cells.
    Kraus P; Pujman V
    Arzneimittelforschung; 1969 Mar; 19(3):356-7. PubMed ID: 4305822
    [No Abstract]   [Full Text] [Related]  

  • 30. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Lee T; Karon M; Monparler RL
    Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of cytosine arabinoside (NSC-63878) in a spectrum of rodent tumors.
    Wodinsky I; Kensler CJ
    Cancer Chemother Rep; 1965 Aug; 47():65-8. PubMed ID: 5829428
    [No Abstract]   [Full Text] [Related]  

  • 32. 2'-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside. Absence of protection of bone marrow lymphocytes.
    Buchman VM; Belyanchikova NI; Mkheidze DM; Litovchenko TA; Lichinitser MR; Barkhotkina MF; Svet-Moldavsky GJ
    Cancer Chemother Pharmacol; 1979; 3(4):229-34. PubMed ID: 535131
    [No Abstract]   [Full Text] [Related]  

  • 33. Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis.
    Plagemann PG; Marz R; Wohlhueter RM
    Cancer Res; 1978 Apr; 38(4):978-89. PubMed ID: 205355
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
    Liss RH; Neil GL
    Cancer Chemother Rep; 1975; 59(3):501-13. PubMed ID: 1203880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of a spectrum of animal tumors by dietary zinc deficiency.
    DeWys W; Pories W
    J Natl Cancer Inst; 1972 Feb; 48(2):375-81. PubMed ID: 4652380
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection of leukemic cells by deoxycytidine: in vitro measures of protection against cytosine arabinoside.
    Cohen JD; Strock DJ; LaGuardia EA; Mao Z; Teik JE
    Leuk Res; 1998 May; 22(5):421-7. PubMed ID: 9652728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract]   [Full Text] [Related]  

  • 38. Resting cells in L1210 and JB-1 ascites tumors with special emphasis on recycling.
    Hartmann NR; Dombernowsky P; Bichel P
    Cancer Treat Rep; 1976 Dec; 60(12):1861-70. PubMed ID: 1026340
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 40. Uptake of cytosine arabinoside (Ara-C) by LSA lymphoma after irradiation in the stationary phase of growth.
    Young JA; Maruyama Y
    Radiology; 1982 Mar; 142(3):759-63. PubMed ID: 7063699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.